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Copyright © 200? JCBN 200? This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Here, we focused on the effects of racemic α-lipoic acid on pro-
liferation and adhesion properties of 3Y1 rat fibroblasts and the
v-H-ras-transformed derivative, HR-3Y1-2 cells. Racemic α-lipoic
acid inhibited proliferation of HR-3Y1-2 but not 3Y1 cells at 0.3
and 1.0 mM. R-(+)-α-lipoic acid also inhibited proliferation of HR-
3Y1-2 cells equivalent to that of racemic α-lipoic acid. In addition,
racemic α-lipoic acid decreased intracellular reactive oxygen species
levels in HR-3Y1 cells but not 3Y1 cells. Next, we evaluated the
effects of racemic α-lipoic acid on cell adhesion to fibronectin. The
results indicated that racemic α-lipoic acid decreased adhesive
ability of HR-3Y1-2 cells to fibronectin-coated plates. As blocking
antibody experiment revealed that β1-integrin plays a key role in
cell adhesion in this experimental system, the effects of racemic
α-lipoic acid on the expression of β1-integrin were examined. The
results indicated that racemic α-lipoic acid selectively down-
regulated the expression of cell surface β1-integrin expression in
HR-3Y1-2 cells. Intriguingly, exogenous hydrogen peroxide up-
regulated cell surface β1-integrin expression in 3Y1 cells. Taken
together, these data suggest that reduction of intracellular reac-
tive oxygen species levels by α-lipoic acid could be an effective
means of ameliorating abnormal growth and adhesive properties
in v-H-ras transformed cells.
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Introduction Ras proteins are oncogene products capable of inducing cell
transformation and are associated with many types of human
cancer. Indeed, ras mutation is recognized in a broad range of
human cancers.(1) Wild-type Ras proteins play a central role in
the regulation of normal cell proliferation, whereas activation
mutation of Ras confers properties of cancer cells, such as
deregulated proliferation.(2,3) Recent data attribute this abnormal
proliferation of cells with activation mutation of ras to over-
activation of NADPH oxidase (Nox1) and resulting reactive oxygen
species (ROS) production.(4–7) The H-ras oncogene induces
constitutive expression of Nox1 through the Raf-MEK-MAPK
pathway and Nox1-generated ROS have an essential mediating
role in ras oncogene transformation phenotypes, including
augmented cell growth, altered cell morphology, anchorage-
independent growth, and tumorigenesis.(8) The HR-3Y1-2 cell line
established by Kimura et al.(9) is derived from 3Y1 rat fibroblasts
transformed with the v-H-ras oncogene. Anchorage-independent
proliferation and changes in cellular morphology are known
features of 3Y1 cells transformed with v-H-ras,(10) and our
previous study showed that HR-3Y1-2 cells are capable of pro-
liferating faster than the parental cell line 3Y1.(11) Therefore, these
cell lines are useful for evaluation of the effects of various
treatments on the malignant characteristics associated with Ras
activation. In addition, ROS production could control the integrin-
related cancer migration, which means that the adhesive ability to
extracellular matrix is maintained in the normal state under the
control of cellular redox conditions.(12) Interfering with tumor cell
attachment with integrin-binding peptides has been shown to be an
effective strategy for antimetastatic therapy.(13)
Alpha-lipoic acid (6,8-dithio octanoic acid; ALA) is a naturally
occurring antioxidative compound and is essential in humans,
functioning as a coenzyme in various biological processes. ALA
is widely distributed as lipoyllysine in vegetables and animal
tissues.(14) Due to its potent antioxidant activity in vitro and in vivo,
it is utilized as a preventive agent in diabetes mellitus, hyper-
tension, and hepatic disorders.(15–17) Therefore, ALA is a promising
agent for amelioration of activated ras-derived malignant charac-
teristics by elimination of ROS. To evaluate this hypothesis, we
evaluated the effects of ALA on proliferation and cell adhesion of
3Y1 and HR-3Y1-2 cells.
Materials and Methods
Chemicals. Racemic or R-(+)-α-Lipoic acid (rac-ALA or R-
(+)-ALA) and 2',7'-dichlorofluorescein diacetate (DCFH-DA) were
purchased from Sigma (St. Louis, MO).
Cell culture. 3Y1 (also called 3Y1-B clone 1-6) and HR-
3Y1-2 cells were purchased from the Japanese Collection of
Research Bioresources (Osaka, Japan). Cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal bovine serum containing 100 units/mL of penicillin
G and 100 μg/mL of streptomycin. Cells were subcultured twice a
week, and in actual in vitro experiments, the cells were seeded at
3.5 × 103 cells/cm2 in 90-mm dishes or 24-well multiwell culture
plates.
Cell cycle analysis. For cell cycle analysis, cells were treated
with or without 1.0 mM rac-ALA for 24 h and the percentage of
each cell cycle population was evaluated by flow cytometric
analysis. Briefly, cells were fixed in 70% methanol for 1 h and
50% ethanol at 4°C overnight. Then, the nuclei were treated with
10 μg/ml propidium iodide and 10 μg/ml RNase. After staining,
cell cycle analysis was performed using a COULTER Epics XL
flow cytometer (Beckman Coulter, Inc., Fullerton, CA) with
MultiCycle software (San Diego, CA).
Intracellular redox state. At the end of the culture period,
cells were washed with ice-cold PBS and stained with 50 μM
DCFH-DA for 30 min at 37°C. After staining, cells were subjected
to flow cytometric analysis (EPICS XL; Beckman Coulter).
Cell adhesion to fibronectin. Cells at growth phase were
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treated with serum-free DMEM for 60 min at 37°C. The cells
pretreated with or without rac-ALA were then recovered and
seeded at 2.0 × 105 cells/well in fibronectin (Fn)-coated 24-well
plates (BD Biosciences, San Jose, CA). After 60 min, floating
cells were removed from the well and adherent cells were counted.
In an antibody blocking experiment, cells were coincubated with
50 μg/mL of purified hamster anti-rat CD29 (Invitrogen, Carlsbad,
CA) or hamster IgM (Beckman Coulter) as an isotype control.
Western blotting analysis. Whole cell β1-integrin and β-
actin were detected by Western blotting analysis. At the end of
the culture period, cells were lysed in 50 mM Tris-HCl (pH 7.5)
containing 150 mM NaCl, 2% Triton X-100, 2 mM EDTA,
50 mM NaF, 30 mM Na4P2O7, and 1/50 vol. protease inhibitor
cocktail (Nacalai Tesque, Kyoto, Japan). Protein concentrations
were measured using the BCA protein assay reagent (Pierce,
Rockford, IL). Lysates containing 10 μg of protein were separated
by electrophoresis on 10% SDS-polyacrylamide gels, and trans-
ferred onto PVDF Hybond-P membranes (Amersham-Pharmacia
Biotech, Buckinghamshire, UK). Blocking was performed using
3% defatted milk in Tris-buffered saline with 0.1% Tween-20
(TTBS), and antibodies were diluted in Can Get Signal solutions 1
and 2 (Toyobo, Tokyo, Japan). Anti-β1-integrin (N-20) and
horseradish peroxidase-conjugated donkey anti-goat IgG were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The
membranes were washed with TTBS after each antibody binding
reaction. Detection of each protein was performed using an ECL
Plus kit (Amersham-Pharmacia).
Cell surface β1-integrin expression. At the end of the
culture period, cells were washed with cold PBS, then incubated
with 2 μg/mL of hamster anti-mouse CD29 FITC-conjugate
(clone HM beta 1-1, AbD Serotec, Kidlington, UK) for 30 min at
4°C. Cells were washed and resuspend into 2% FBS, 2 mM
Fig. 1. Effects of ALA on proliferation of 3Y1 or HR-3Y1-2 cells. Cultures were treated with 0, 0.1, 0.3, 1.0 mM rac-ALA (A) or R-(+)-ALA (B) for 24 h.
Results are means ± SD of 3 samples. Values marked with a dagger mark or asterisk are significantly different from the data in 3Y1 control or
control value in each cell line at Values marked with a dagger mark or asterisk are significantly different from the data in 3Y1 control or control
value in each cell line at p<0.05, respectively. Open column shows 3Y1 cells and shaded column shows HR-3Y1-2 cells and “None” means that cells
were not treated with ALA.
Fig. 2. Intracellular ROS levels in 3Y1 and HR-3Y1-2 cells. Cells were treated with 0, 0.1, 0.3, 1.0 mM rac-ALA for 12 h (A), 0, 1.0 mM rac-ALA for 0,
3, 6, 12 h (B). The production of ROS was measured using the oxidation-sensitive fluorescent probe 2'7'-dichlorodihydrofluorescin diacetate. Results
are means ± SD of 3 independent experiments. Values marked with a dagger mark or asterisk are significantly different from the data in 3Y1
control or control value in each cell line at p<0.05, respectively. Open column shows 3Y1 cells and shaded column shows HR-3Y1-2 cells and “None”
means that cells were not treated with rac-ALA.doi: 10.3164/jcbn.11-67
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EDTA/PBS and subjected flow cytometric analysis (EPICS XL).
Cells were stained with 10 μg/ml propidium iodide to eliminate
dead cell from analysis.
Statistical analysis. Statistical analysis was done with 4 Steps
Statcel2 software (OMS Publishing, Saitama, Japan). Data were
analyzed by the Tukey-Kramer test, and differences at p<0.05
were considered significant.
Results
Growth inhibition and cell cycle anaysis. First, we eva-
luated the effects of rac-ALA on the growth of 3Y1 and HR-3Y1-
2 cells. The results indicated that 0.3 and 1.0 mM rac-ALA
significantly prevented the growth of HR-3Y1-2 but not 3Y1 cells
at 24 h. (Fig. 1A). To know whether two enantiometric forms of
ALA has different effect on the proliferation of HR-3Y1-2 cells,
Table 1. Effect of racemic alpha-lipoic acid on the cell cycle progression of 3Y1 cells and HR-3Y1-2 cells
Data are means ± SD for 3 samples. Values with asterisk mark(s) are significantly different from the None in each cell cycle phase.
rac-ALA (mM)
None 0.1 0.3 1
3Y1 Distribution (%)
G1 50.6 ± 0.6 51.3 ± 2.6 54.3 ± 2.2 54.6 ± 2.1
S3 9 . 7 ± 1.7 38.9 ± 4.0 34.8 ± 4.7 35.7 ± 0.5
G2/M 9.5 ± 2.3 9.6 ± 2.1 10.7 ± 2.6 9.5 ± 2.0
HR-3Y1-2 Distribution (%)
G1 33.9 ± 0.2 35.3 ± 0.4 38.9 ± 0.8* 45.0 ± 0.7*
S5 4 . 0 ± 2.7 54.5 ± 0.4 49.9 ± 3.0 45.4 ± 3.4*
G2/M 12.0 ± 2.6 10.0 ± 0.7 11.0 ± 3.4 9.5 ± 2.8
Fig. 3. Adhesion of 3Y1 and HR-3Y1-2 cells to fibronectin. Cells were treated with 0, 0.1, 0.3, 1.0 mM rac-ALA for 48 h (A) or 0, 1.0 mM rac-ALA for
0, 12, 24, 48 h (B) and then incubated in fibronectin-coated plates at 37°C for 60 min. In the antibody blocking experiment, cells were incubated
with anti-β1-integrin antibody (50 μg/mL) (C) or hamster IgM (50 μg/mL) as an isotype control (D). Floating cells were removed and adherent cells
were counted. Results are means ± SD of 3 samples. Values marked with a dagger mark or asterisk are significantly different from the data in 3Y1
control or control value in each cell line at p<0.05, respectively. Open column shows 3Y1 cells and shaded column shows HR-3Y1-2 cells and “None”
means that cells were not treated with rac-ALA. J. Clin. Biochem. Nutr. | May 2012 | vol. 50 | no. 3 | 237
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cells were treated with 0, 0.1, 0.3 and 1.0 mM R-(+)-ALA. As a
result,  R-(+)-ALA also inhibited proliferation of HR-3Y1-2
equivalent to that of rac-ALA. To determine if rac-ALA regulated
cell cycle progression, cells were treated with 0 to 1.0 mM rac-
ALA and subjected to cell cycle analysis. Results showed that the
G1 phase cell population was increased with decrease of S phase
distribution at 0.3 and 1.0 mM rac-ALA treatment in HR-3Y1-2
cells (Table 1), whereas rac-ALA did not affect the cell cycle
progression on the 3Y1 cells.
Intracellular ROS level. To evaluate the relationship between
ROS accumulation and HR-3Y1-2-selective inhibition of pro-
liferation, cells were stained with DCFH-DA to determine intra-
cellular ROS levels in 3Y1 and HR-3Y1-2 cells. Intracellular
ROS levels were slightly higher in HR-3Y1-2 cells than in 3Y1
cells. The results indicated that rac-ALA at 0.1, 0.3 and 1.0 mM
treatment for 12 h caused a substantial decrease in intracellular
ROS level at 12 h HR-3Y1-2 cells (Fig. 2 A and B). In contrast,
rac-ALA induced no changes in 3Y1 cells.
Cell adhesion to fibronectin. As  rac-ALA selectively
inhibited the proliferation of HR-3Y1-2 cells and cellular ROS
level, we next evaluated the effects of rac-ALA on integrin-related
cell adhesion. As shown in Fig. 3, HR-3Y1-2 cells had greater
adhesive ability to fibronectin-coated plates. HR-3Y1-2 cells
pretreated with 0.1, 0.3 and 1.0 mM rac-ALA for 48 h (Fig. 3A)
or 1.0 mM for 12, 24 and 48 h (Fig. 3B) showed reduced adhesion
to fibronectin-coated plates. On the other hand, rac-ALA did not
affect the adhesive ability of 3Y1 cells (Fig. 3 A and B). β1-
Integrin blocking antibody inhibited the adhesion of 3Y1 and
HR-3Y1-2 cells by 51% and 57%, respectively (Fig. 3C). Hamster
IgM used as an isotype control did not affect adhesive ability of
both cell lines (Fig. 3D). This result indicated that adhesion of
these cell lines to fibronectin is due to β1-integrin and fibronectin
interaction.
Whole cell β1-integrin expression. As shown in Fig. 3,
β1-integrin plays a pivotal role in adhesion to fibronectin in these
cell lines. We next examined whether rac-ALA could down-
regulate β1-integrin expression in HR-3Y1-2 cells. Fig. 4 A and B
show representative blotting pictures of β1-integrin expression
and intensity of bands on a blot was quantified and shown in Fig. 4
C and D. Basically, untreated HR-3Y1-2 cells expressed higher
levels of β1-integrin than 3Y1 cells. rac-ALA at 1.0 mM but not
at 0.1 and 0.3 mM significantly downregulated the expression of
β1-integrin at 48 h in HR-3Y1-2 cells, whereas its expression was
unaffected by rac-ALA treatment in 3Y1 cells.
Cell surface β1-integrin expression. Next, cell surface β1-
integrin expression was also examined. HR-3Y1-2 cells treated
with 0.1, 0.3 and 1.0 mM rac-ALA for 48 h (Fig. 5A) or 1.0 mM
for 12, 24 and 48 h (Fig. 5B) showed reduced expression of cell
surface β1-integrin. To reveal whether exogenous oxidative stress
evokes HR-3Y1-2 like phenotype in 3Y1 cells, cell surface β1-
integrin expression in 3Y1 cells treated with hydrogen peroxide.
Result showed exogenous hydrogen peroxide dose-dependently
unregulated cell surface β1-integrin expression in 3Y1 cells and
cells treated with 100 μM hydrogen peroxide for 48 h expressed
comparable level of cell surface β1-integrin with HR-3Y1-2 cells
(Fig. 5C).
Discussion
Ras is known to play a pivotal role in regulating cell prolifera-
tion by activation of mitogen-activated protein kinase and
phosphoinositide 3-kinase pathways,(2,3) and mutations leading to
activation of these cascades result in abnormal growth. There is
accumulating evidence that activation mutation of H-ras triggers
the activation of Nox1 and the resultant ROS production plays
important roles in the malignant characteristics of ras-transformed
Fig. 4. β1-Integrin protein expression in 3Y1 and HR-3Y1-2 cells. Cells were treated with 0, 0.1, 0.3, 1.0 mM rac-ALA for 48 h (A, C) or 0, 1.0 mM rac-
ALA for 0, 12, 24, 48 h (B, D). β1-Integrin protein was detected by western blotting and representative image data were shown in A and B, density
of each band was quantified as a ratio of β1-integrin/β-actin and shown in C and D. The methods are described in detail in Materials and Methods.
Results in C and D are means ± SD of 3 independent experiments. Values marked with a dagger mark or asterisk are significantly different from the
data in 3Y1 control or control value in each cell line at p<0.05, respectively. Open column shows 3Y1 cells and shaded column shows HR-3Y1-2 cells
and “None” and “N” mean that cells were not treated with rac-ALA.doi: 10.3164/jcbn.11-67
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cells.(4–7) These results provide new insight into the mechanism
by which antioxidants could decrease excess intracellular ROS
then inhibit abnormal proliferation. Our data clearly showed that
HR-3Y1-2 cells have higher levels of intracellular ROS than 3Y1
cells. In addition, the growth rate, ability to adhere to fibronectin,
and β1-integrin expression of HR-3Y1-2 cells were higher than
those of 3Y1 cells. ROS behaves as a second messenger to activate
the ERK pathway, which is a representative mitogenic signaling
pathway.(18) Therefore, the observation that HR-3Y1-2 cells could
proliferate faster than 3Y1 cells is convincing. Therefore, 3Y1
and HR-3Y1-2 cells are considered appropriate cell lines for
evaluation of the effects of antioxidants on v-H-ras mediated
transformation.
Several studies have shown that ALA elicits apoptotic cell
death or growth arrest in several cancer cell lines.(19–22) However,
the detailed mechanism remains to be elucidated. On the other hand,
ALA is capable of preventing apoptotic cell death under condi-
tions of oxidative stress because of its antioxidant activity.(23,24)
The results of the present study indicated that rac-ALA down-
regulates intracellular ROS level accompanied by inhibition of
cell proliferation in HR-3Y1-2 cells, whereas rac-ALA does not
affect ROS level or cell proliferation of 3Y1 cells at 1.0 mM. In
addition, our present data revealed that R-(+)-ALA and rac-ALA
had comparable ability of inhibiting proliferation of HR-3Y1-2
cells, suggesting naturally occurring ALA is capable of inhibiting
the proliferation of v-H-ras transformed cells. Since, Smith et al.(25)
reported that protective effect against oxidative damage of ALA
is different among the type of optical isomer and cell type, our
subject for further study is to demonstrate the effect of ALA on
various v-H-ras transformed cells and apply to human cancer cells
with H-ras mutation.
As shown in Table 1, growth-inhibitory action of rac-ALA on
HR-3Y1-2 cells is attributable to cell cycle delay at G1 phase.
Such reduction of intracellular ROS may be explained on the basis
of several previous reports. First, ALA and its reduced form,
dihydrolipoic acid (DHLA), are capable of scavenging a variety of
ROS and reactive nitrogen species.(26) Moreover, as the reduction
of ALA to DHLA requires NADPH consumption,(27) NADPH
starvation may indirectly prevent NADPH oxidase-derived ROS
production. Secondly, LA appears to be a potent inducer of
Nrf 2-mediated antioxidant gene expression, which leads to
increase or maintenance of intracellular GSH.(28,29) Actually,
Moini  et al.(30) revealed that R-(+)-LA significantly increased
cellular reduced glutathione level and at the same time points the
Fig. 5. Cell surface β1-integrin protein expression in 3Y1 and HR-3Y1-2 cells. Cells were treated with 0, 0.1, 0.3, 1.0 mM rac-ALA for 48 h (A), 0,
1.0 mM rac-ALA for 0, 12, 24, 48 h (B) or 0, 10, 50, 100 μM hydrogen peroxide for 48 h (C). The methods are described in detail in Materials and
Methods. Results in A–C are means ± SD of 3 independent experiments. Values marked with a dagger or asterisk(s) are significantly different from
the control of 3Y1 cells or control of each cell line at p<0.05, respectively. Open column shows 3Y1 cells and shaded column shows HR-3Y1-2 cells
and “None” means that cells were not treated with rac-ALA. J. Clin. Biochem. Nutr. | May 2012 | vol. 50 | no. 3 | 239
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intracellular level of oxidants was decreased.
Excess intracellular ROS controls cancer metastasis and inva-
sion by disruption of normal expression of adhesive molecules.
For example, upregulation of intracellular ROS by Helicobacter
pylori infection leads to an increase in β1-integrin expression.(31)
Our data also indicated that whole cell and cell surface β1-integrin
expression is upregulated in HR-3Y1-2 cells to a greater extent
than 3Y1 cells. β1-Integrin can form heterodimers with αv, α5
and  α8 chain, and these complexes have been implicated in
interaction with fibronectin. Therefore, upregulation of β1-integrin
expression in HR-3Y1-2 cells is considered to result in high
adhesive ability to fibronectin. Especially, some tumor cells
express high levels of α4β1 and α5β1 integrin in association
with malignant phenotypes, such as metastasis and anchorage-
independent proliferation. Consistent with these reports, our data
indicated that HR-3Y1-2 cells had higher ability to adhere to
fibronectin than 3Y1 cells. Moreover, as the blocking experiment
indicated that adhesion of 3Y1 and HR-3Y1-2 cells was sub-
stantially prevented by anti-β1-integrin antibody, β1-integrin
plays a pivotal role in adhesion with fibronectin in both cell lines.
Intriguingly, rac-ALA treatment prevented adhesion of HR-3Y1-
2 cells to fibronectin at 0.1, 0.3 and 1.0 mM (Fig. 3) with down-
regulation of cell surface β1-expression (Fig. 5). On the other
hand, although 1.0 mM rac-ALA surely downregulated whole cell
β1-integrin expression in HR-3Y1-2, low concentrations of rac-
ALA (0.1, 0.3 mM) could not. These data suggest that rac-ALA
reduced adhesive ability of HR-3Y1-2 cells to fibronectin through
downregulation of cell surface β1-integrin expression by regu-
lating its cellular localization. It is increasingly evident that cell
surface β1-integrin level is regulated by its dynamic internaliza-
tion and recycling process.(32,33) As downregulation of cell surface
β1-integrin by rac-ALA was apparent after 12 h of treatment as
shown in Fig. 5, which was after ROS inhibition, downregulation
of cell surface β1-integrin expression in HR-3Y1-2 cells is
dependent on ROS-related pathways. Moreover, exogenous
hydrogen peroxide is capable of upregulating cell surface β1-
integrin expression in 3Y1 cells (Fig. 5C). On the contrary,
exogenous hydrogen peroxide downregulates β1-integrin expres-
sion in promyelocytic leukemia.(34) These information indicate
that intracellular ROS manipulates β1-integrin expression.
We can’t avoid discussing about another plausible mechanism
of ALA. ALA may directly interact with cysteine residue of the
proteins involved in various cellular signaling pathways. For
instance, ALA downregulates phosphatases such as PP2A through
the redox modulation of cysteine residues because ALA occurs
thiol-disulfide exchange between ALA and protein sulfhydryls.(29)
As PP2A has positive role in H-ras dependent activation of Raf-1
which consequently activates ERK pathway,(35) ALA promises
downregulation of ERK pathway through inactivation of PP2A.
On the other hand, as cysteine-rich-domain in Raf-1 protein is also
involved its activation and ERK2 also has cysteine residue in its
active site, the interaction between ALA and cysteine residue(s) in
these or other signaling proteins is mostly unknown. Further
studies are needed to focus on the molecular mechanism of ALA
including redox modulation of signaling molecules.
Taken together, ALA is a promising agent to decrease intra-
cellular ROS and ameliorate the malignant characteristics of v-Ha-
ras-transformed cells.
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